Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 Cell Extracts Inhibit Adipogenesis in 3T3-L1 and HepG2 Cells

Journal of Medicinal Food
Woon Hee JeungJung-Lyoul Lee

Abstract

Some lactic acid bacteria (LAB) and their cellular components have antiobesity effects. In this study, we evaluated the antiadipogenic effects of a mixture of two LAB-Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032-using 3T3-L1 preadipocytes and HepG2 hepatocarcinoma cells. 3T3-L1 cells treated with a 1:1 ratio of HY7601 and KY1032 during differentiation showed reduced lipid accumulation by Oil Red O staining, as well as decreased leptin secretion and mRNA expression of peroxisome proliferator-activated receptor-γ and CCAAT/enhancer binding protein-α. HY7601 and KY1032 treatment also suppressed mitochondrial biogenesis and inhibited the expression of genes encoding mitochondrial transcription factors, as well as those related to fatty acid synthesis in HepG2 cells. The antiadipogenic effects of LAB were associated with the cell membrane fraction. These results demonstrate that a mixture of two LAB (HY7601 and KY1032) inhibits adipogenesis in preadipocytes and liver cells and is a potential therapeutic strategy for the treatment of obesity.

References

Jul 1, 1993·Comparative Biochemistry and Physiology. Comparative Physiology·A Suryawan, C Y Hu
Mar 1, 1997·Progress in Lipid Research·C F Semenkovich
Jun 11, 1998·Journal of Animal Science·K L HouseknechtM E Spurlock
Apr 15, 2000·Nature·P G Kopelman
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·J YangJ D Horton
Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Aug 9, 2005·International Journal of Food Microbiology·Myungjin Kim, Jongsik Chun
Oct 6, 2005·The Journal of Clinical Endocrinology and Metabolism·Iwona BogackaSteven R Smith
Dec 22, 2006·Nature·Peter J TurnbaughJeffrey I Gordon
Nov 1, 2007·Nutrition & Metabolism·Amanda M Gonzales, Robert A Orlando
Apr 3, 2008·Mayo Clinic Proceedings·John K DiBaiseBruce E Rittmann
May 27, 2008·Experimental Cell Research·Anja ZeigererJeffrey M Friedman
Sep 29, 2011·Nature Reviews. Molecular Cell Biology·Ana G Cristancho, Mitchell A Lazar
Sep 5, 2012·Nature Reviews. Gastroenterology & Hepatology·Harry J FlintSylvia H Duncan
Apr 17, 2013·International Journal of Molecular Medicine·Junpeng YangLi Chen
Jul 3, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Shu-Jing WuLean-Teik Ng
Dec 10, 2013·The Journal of Nutritional Biochemistry·Shu WangChwan-Li Shen
Jan 24, 2014·Journal of the Science of Food and Agriculture·Jeong-Eun ParkYoun-Soo Cha
Mar 6, 2015·Biological Reviews of the Cambridge Philosophical Society·Francis W B Sanders, Julian L Griffin
Jun 3, 2015·Nutrition Research·Sunmin Park, Ji-Hyun Bae
Apr 20, 2017·Frontiers in Microbiology·Dinesh K DahiyaPratyoosh Shukla

❮ Previous
Next ❯

Citations

Feb 23, 2021·Journal of Dairy Science·Ji Soo LeeSeok-Seong Kang

❮ Previous
Next ❯

Datasets Mentioned

BETA
KY1032

Methods Mentioned

BETA
Reverse Transcription Polymerase Chain Reaction
reverse transcription PCR

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.